International fashion lifestyle brand Folli Follie has collaborated with Breast Cancer Care for Breast Cancer Awareness Month.
The support the UK-based charity, Folli Follie will be donating 10% of sales from the brand’s meaningful ‘Heart4Heart’ collection, and the company will be the headline sponsor for Breast Cancer Care’s show in London on November 2.
The timeless Heart4Heart collection offers sophisticated jewellery, classic watches and statement handbags and accessories, designed to make every woman look and feel her best.
Each piece features the brand’s signature interlocking heart motif symbolising; Hope, Love, Beauty and Promise.
As the proud headline sponsor of The Show London, the brand helps to celebrate 32 courageous women and men as they take to the catwalk following a breast cancer diagnosis, to show that you can still look and feel amazing after diagnosis and treatment.
Folli Follie Group vice president, Ketty Koutsolioutsos, comments: ‘We are proud to be working with Breast Cancer Care and hope that with our aid they may continue to support women affected by breast cancer.
“Folli Follie has always invested in long lasting charitable initiatives, both in its native Greece and globally, and as a leading women’s fashion brand this is a charity close to our hearts.”
Folli Follie will also be fundraising for Breast Cancer Care inside the brand’s boutiques. Tonight Folli Follie will be hosting a ‘Drink Pink’ event the flagship store on Oxford street.
Samia al Qadhi, chief executive at Breast Cancer Care, adds: “We are delighted Folli Follie has come on board as one of our new corporate supporters, and as the new headline sponsor of this year’s Breast Cancer Care Show London. As well as being the main sponsor of this glamorous event, the next year will see some fantastic events and fundraising in their stores, as well as the donations from the Heart4Heart collection. Every penny raised will help Breast Cancer Care to continue to provide a lifeline of care, support and information for anyone affected by breast cancer.”